Business news – Page 72
-
Business
FDA accused of violating drug company’s freedom of speech
Amarin says the regulator is stopping it from giving ‘truthful, not misleading’ information to doctors about its fatty acid drug
-
Business
Alexion to buy Synageva for rare disease drugs
$8.4bn deal gives firm access to enzyme drug currently under review with US and EU regulators
-
Business
Takeda offers $2.4bn to settle diabetes litigation
Aims to settle multiple outstanding lawsuits relating to Actos (pioglitazone) and bladder cancer
-
Business
Zoetis to sell or close 10 plants in cost-cutting drive
Animal health firm will slash product portfolio in a bid to save $300m annually
-
BusinessKolon and Dupont settle trade secrets case
Korean firm admits stealing Kevlar technology and will pay $360m in fines and restitution
-
Business
Dow to shed up to 1750 jobs by 2017
Chemical giant will lay off about 3% of its global workforce in the next two years
-
BusinessMerger creates biggest supplier of unlicensed drugs
Clinigen will buy Idis to consolidate different routes by which doctors can access medicines that are unavailable locally
-
BusinessGenerics firms in three-way takeover battle
Mylan is chasing Perrigo, while fending off advances from Teva
-
OpinionFlexible, faster formulation
The chemical using industries remain central to UK economic recovery, explains Simon Rushworth
-
OpinionMissing mathematics?
While you may not need differential calculus every day, mathematics is the basis of scientific thinking, says Derek Lowe
-
Business
Daiichi Sankyo steps out after Sun-Ranbaxy merger
Ranbaxy’s Japanese owner has sold off its stake in the merged company, but will retain its business partnership
-
FeatureCrossing the valley of death
Katrina Krämer examines efforts to bridge the gap between university research and commercial products
-
Business
Generics giant Mylan offers $30 billion for Perrigo
Mylan makes ambitious takeover offer just weeks after Abbott aquisition closes
-
Business
BMS invests in gene therapy
Bristol-Myers Squibb makes $100 million deal with biotech uniQure
-
Business
Leak causes explosion at para-xylene plant in China
Twelve injured by explosion and fire caused by a leaking xylene tank at chemical plant
-
Business
Novartis accused of ‘derailing’ trials for cheap eye disease drug
BMJ says pharma giant is trying to block access to a drug that would save the NHS millions
-
Business
Horizon to acquire orphan drugs in $1.1bn Hyperion takeover
Horizon will buy Hyperion and add new drugs to its rare disease portfolio
-
BusinessEnvironmental research goes private
Exclusive interview with Fera chief Hilary Aldridge as the UK’s Food and Environment Research Agency becomes majority-owned by Capita
-
Business
Dow sells off chlorine assets in $5bn deal
US chemical giant disposes of unwanted operations in tax-free deal